| Literature DB >> 30009812 |
Emad Khalilzadeh1, Farzin Azarpey2, Reza Hazrati3, Gholamreza Vafaei Saiah2.
Abstract
It seems that histamine release in the site of neuronal injury could contribute to the neuropathic pain mechanism. In the present study, we investigated the anti-allodynic effects of chronic administration of different classes of histamine H1 and H2 receptor antagonists on neuropathic nociceptive behavior following tibial nerve transection (TNT) in rats. Peripheral neuropathy was induced by TNT surgery. We performed acetone tests (AT) to record cold allodynia, Von Frey tests (VFT) to measure mechanical allodynia, double plate test (DPT) to evaluate thermal place preference/avoidance and open field test (OFT) for evaluation of animal activity. TNT rats showed a significant mechanical and cold allodynia compared to the sham group. Chlorpheniramine (5 and 15 mg/kg, i.p) significantly attenuated cold allodynia and prevented cold plate avoidance behavior and at the dose of 15 mg/kg remarkably decreased mechanical allodynia. Fexofenadine (10 and 30 mg/kg, p.o) significantly attenuated the mechanical allodynia and prevented cold plate avoidance. Ranitidine (5 and 15 mg/kg, i.p) significantly prevented cold plate avoidance behavior and at the dose of 15 mg/kg notably improved mechanical and cold allodynia. Famotidine (1 and 3 mg/kg, p.o) was ineffective on all nociceptive tests. Gabapantin (100 mg/kg, p.o) significantly improved all types of nociceptive behaviors. These results indicate that both blood brain barrier penetrating (chlorpheniramine) and poorly penetrating (fexofenadine) histamine H1 receptor antagonists could improve the neuropathic pain sign, but only the blood brain barrier penetrating histamine H2 receptor antagonist (ranitidine) could produce anti-allodynic effects in the TNT model of neuropathic pain in rats.Entities:
Keywords: Allodynia; Chlorpheniramine maleate (PubChem CID: 8231); Double plate test; Gabapantin; Histamine; Ketamine hydrochloride (PubChem CID: 15851); Neuropathic pain; Rats; carboxymethylcellulose (PubChem CID: 24748); famotidine hydrochloride (PubChem CID: 56841564); fexofenadine hydrochloride (PubChem CID: 63002); gabapentin (PubChem CID: 3446); ranitidine hydrochloride (PubChem CID: 3033332); xylazine hydrochloride (PubChem CID: 68554)
Mesh:
Substances:
Year: 2018 PMID: 30009812 DOI: 10.1016/j.ejphar.2018.07.011
Source DB: PubMed Journal: Eur J Pharmacol ISSN: 0014-2999 Impact factor: 4.432